Cellebrite DI (CLBT) Total Current Liabilities (2020 - 2026)

Cellebrite DI has reported Total Current Liabilities for 7 years, with the latest figure at $364.2 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 17.5% year-over-year to $364.2 million in Q2 2026; TTM through Jun 2026 was $364.2 million, a 17.5% increase from a year earlier, with the FY2025 full-year figure at $369.7 million, up 25.09% from the prior year.
• Total Current Liabilities was $364.2 million for Q2 2026 at Cellebrite DI, up from $350.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $369.7 million in Q4 2025, with the low at $170.6 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $259.4 million, with a median of $245.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities slumped 52.99% in 2022, then jumped 30.66% in 2025.
• Over 5 years, Total Current Liabilities stood at $207.8 million in 2022, then increased by 22.16% to $253.8 million in 2023, then increased by 16.42% to $295.5 million in 2024, then advanced by 25.09% to $369.7 million in 2025, then dropped by 1.47% to $364.2 million in 2026.
• The last three Total Current Liabilities figures came in at $364.2 million (Q2 2026), $350.2 million (Q1 2026), and $369.7 million (Q4 2025), per Business Quant data.